SLN ▼ -0.6% - Silence Therapeutics plc $SLN reported Q3 2026 EPS of -$0.24, missing the -$0.12 estimate by 100.0%. Revenue of $0 missed the $20,830 estimate by 100.0%. 12-NOV-2026 08:35 AM ET